Deven Choksey of KR Choksey Investment Managers told CNBC-TV18, "For Cipla, what is more interesting is that they are paying the price three times the turnover that the company is making. Something which I am very comfortable about is when you generally end up with a major ratio of paying the valuations, you remain definitely positive on such companies and acquisitions. More importantly, on one side you have the manufacturing, you also have the product portfolio and then at the same time you are getting the distribution part in the US market. So all in all put together it is a good combination that you get through such acquisition. Certainly remaining positive on this aspect.""Look at the kind of kind of preparation the company has made in the backend, the kind of formulation facilities, the generic manufacturing facilities that they have already built in, probably that could plug in very fast with this kind of frontend acquisition that they have done. So, certainly remaining positive on the company," he said. "Certainly there is no hesitation in putting buy recommendation across. Of course the view point would be for two years and above, those who want to create a portfolio for two years and above, certainly a good choice to add into the portfolio," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
